Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 31 - 40 of 426 items for :

  • "Guidelines" x
Clear All
P. Beck-Peccoz Department of Clinical Sciences and Community Health, University of Milan, Endocinology and Diabetology Unit, Fondazione IRCCS Cà Granda Policlinico

Search for other papers by P. Beck-Peccoz in
Google Scholar
PubMed Close
,
A. Lania Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, University of Milan, Endocrine Unit, Istituto Clinico Humanitas IRCCS, Rozzano, Milan, Italy

Search for other papers by A. Lania in
Google Scholar
PubMed Close
,
A. Beckers Service d'Endocrinologie, Centre Hospitalier Universitaire de Liège, Université de Liège, Liège, Belgium

Search for other papers by A. Beckers in
Google Scholar
PubMed Close
,
K. Chatterjee Institute of Metabolic Science, Metabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK

Search for other papers by K. Chatterjee in
Google Scholar
PubMed Close
, and
J.-L. Wemeau CHRU, Hôpital Claude-Huriez, Clinique Endocrinologique Marc-Linquette, Lille, France

Search for other papers by J.-L. Wemeau in
Google Scholar
PubMed Close

.328.7454.1490 15205295 8 Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schunemann HJ: Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, ed 8. Chest 2008

Article Type:
Guideline
DOI:
https://doi.org/10.1159/000351007
Volume/Issue:
Volume 2: Issue 2
Free access
Richard T. Kloos Divisions of Endocrinology, Diabetes and Metabolism, and Nuclear Medicine, Departments of Internal Medicine and Radiology, The Ohio State University, Columbus, Ohio, USA

Search for other papers by Richard T. Kloos in
Google Scholar
PubMed Close

Introduction The European Thyroid Association (ETA) launched a taskforce, chaired by Martin Schlumberger, to create guidelines on the treatment of metastatic medullary thyroid cancer (MTC) [ 1 ]. The decision to create a focused guideline

Article Type:
Editorial
DOI:
https://doi.org/10.1159/000337054
Volume/Issue:
Volume 1: Issue 1
Free access
Laura Fugazzola Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Search for other papers by Laura Fugazzola in
Google Scholar
PubMed Close
,
Rossella Elisei Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed Close
,
Dagmar Fuhrer Department of Endocrinology, Diabetes and Metabolism, Endocrine Tumour Center at West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany

Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed Close
,
Barbara Jarzab Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Barbara Jarzab in
Google Scholar
PubMed Close
,
Sophie Leboulleux Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, Villejuif, France

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed Close
,
Kate Newbold Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom

Search for other papers by Kate Newbold in
Google Scholar
PubMed Close
, and
Jan Smit Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Jan Smit in
Google Scholar
PubMed Close

Premise Few prospective studies are available on the management of patients with advanced thyroid cancer (TC), and the decision making is mostly based on the personal experience of physicians. The present guidelines are mainly based on the

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000502229
Volume/Issue:
Volume 8: Issue 5
Free access
Leonidas H. Duntas Endocrine Unit, Evgenidion Hospital, University of Athens, Athens, Greece

Search for other papers by Leonidas H. Duntas in
Google Scholar
PubMed Close
,
Georg Brabant Medizinische Klinik I, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany

Search for other papers by Georg Brabant in
Google Scholar
PubMed Close
,
Fabio Monzani Department of Clinical and Experimental Medicine, Università di Pisa, Pisa, Italy

Search for other papers by Fabio Monzani in
Google Scholar
PubMed Close
,
Simon H.S. Pearce Institute of Genetic Medicine, Newcastle University, UK
Royal Victoria Infirmary, Newcastle upon Tyne, UK

Search for other papers by Simon H.S. Pearce in
Google Scholar
PubMed Close
,
Robin Patrick Peeters Rotterdam Thyroid Center, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands

Search for other papers by Robin Patrick Peeters in
Google Scholar
PubMed Close
,
Salman Razvi Institute of Genetic Medicine, Newcastle University, UK
Queen Elizabeth Hospital, Gateshead, UK

Search for other papers by Salman Razvi in
Google Scholar
PubMed Close
, and
Jean-Louis Wemeau Clinique Endocrinologique Marc-Linquette, CHU, Lille, France

Search for other papers by Jean-Louis Wemeau in
Google Scholar
PubMed Close

We appreciate the interest of Stott et al. [ 1 ] in the Management of Subclinical Hypothyroidism ETA Guidelines 2013 [ 2 ]. We are, however, somewhat puzzled by the authors' statement that the guidelines ‘risk doing more harm than good

Article Type:
Letter
DOI:
https://doi.org/10.1159/000360622
Volume/Issue:
Volume 3: Issue 2
Free access
Luigi Bartalena Department of Clinical and Experimental Medicine, University of Insubria, Endocrine Unit, Ospedale di Circolo, Varese, Italy

Search for other papers by Luigi Bartalena in
Google Scholar
PubMed Close
,
Lelio Baldeschi Department of Ophthalmology, Hospital Saint Luc, Catholic University of Louvain, Brussels, Belgium

Search for other papers by Lelio Baldeschi in
Google Scholar
PubMed Close
,
Kostas Boboridis Ophthalmology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece

Search for other papers by Kostas Boboridis in
Google Scholar
PubMed Close
,
Anja Eckstein Zentrum für Augenheilkunde, Universitätsklinikum Essen, Essen

Search for other papers by Anja Eckstein in
Google Scholar
PubMed Close
,
George J. Kahaly Department of Medicine I, Johannes Gutenberg University (JGU) Medical Center, Mainz, Germany

Search for other papers by George J. Kahaly in
Google Scholar
PubMed Close
,
Claudio Marcocci Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Claudio Marcocci in
Google Scholar
PubMed Close
,
Petros Perros Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Search for other papers by Petros Perros in
Google Scholar
PubMed Close
,
Mario Salvi Graves' Orbitopathy Center, Endocrinology, Fondazione Ca' Granda IRCCS, University of Milan, Milan, Italy

Search for other papers by Mario Salvi in
Google Scholar
PubMed Close
, and
Wilmar M. Wiersinga Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed Close

been in widespread use ever since. Guidelines for the management of hyperthyroidism by the American Thyroid Association and American Association of Clinical Endocrinologists were published in 2011; recommendations were made on how hyperthyroidism should

Article Type:
Guideline
DOI:
https://doi.org/10.1159/000443828
Volume/Issue:
Volume 5: Issue 1
Free access
Petros Perros Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK

Search for other papers by Petros Perros in
Google Scholar
PubMed Close

References 1 Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MPJ: 2012 ETA Guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J 2012;1:55–71. 2 Bunevicius R, Kazanavicius G, Zalinkevicius R

Article Type:
Editorial
DOI:
https://doi.org/10.1159/000338637
Volume/Issue:
Volume 1: Issue 2
Free access
Salman Razvi Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

Search for other papers by Salman Razvi in
Google Scholar
PubMed Close
,
Bronia Arnott Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

Search for other papers by Bronia Arnott in
Google Scholar
PubMed Close
,
Dawn Teare Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

Search for other papers by Dawn Teare in
Google Scholar
PubMed Close
,
Shaun Hiu Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

Search for other papers by Shaun Hiu in
Google Scholar
PubMed Close
,
Nicki O’Brien Department of Psychology, Northumbria University, Newcastle upon Tyne, United Kingdom

Search for other papers by Nicki O’Brien in
Google Scholar
PubMed Close
, and
Simon H. Pearce Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

Search for other papers by Simon H. Pearce in
Google Scholar
PubMed Close

not specifically highlight that age should be a criterion when considering treatment in patients with mild SCH, although it does state that normal serum TSH reference range changes with age [ 20 ]. It is unclear whether guidelines formulated by these

Article Type:
Research Article
Collections:
Hypothyroidism
DOI:
https://doi.org/10.1159/000509228
Volume/Issue:
Volume 10: Issue 4
Free access
X Y Hu Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by X Y Hu in
Google Scholar
PubMed Close
,
J Wu Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by J Wu in
Google Scholar
PubMed Close
,
P Seal EFW Radiology, Calgary, Alberta, Canada

Search for other papers by P Seal in
Google Scholar
PubMed Close
,
S A Ghaznavi Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Department of Medicine, Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by S A Ghaznavi in
Google Scholar
PubMed Close
,
C Symonds Department of Medicine, Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by C Symonds in
Google Scholar
PubMed Close
,
S Kinnear Department of Medicine, Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by S Kinnear in
Google Scholar
PubMed Close
, and
R Paschke Department of Medicine, Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by R Paschke in
Google Scholar
PubMed Close

Introduction Thyroid ultrasound (TUS) is the most sensitive and cost-effective modality for the evaluation of thyroid nodules ( 1 ). When thyroid nodules are incidentally discovered on other imaging modalities, current guidelines suggest that

Article Type:
Research Article
Collections:
Goiter and thyroid nodules
DOI:
https://doi.org/10.1530/ETJ-22-0035
Volume/Issue:
Volume 11: Issue 3
Open access
Kris Poppe Endocrine Unit, Department of Internal Medicine, University Hospital UZ Brussel (VUB), Brussels, Belgium

Search for other papers by Kris Poppe in
Google Scholar
PubMed Close
,
Alicja Hubalewska-Dydejczyk Department of Endocrinology, Jagiellonian University Medical College, Kraków, Poland

Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed Close
,
Peter Laurberg Department of Endocrinology and Medicine, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark

Search for other papers by Peter Laurberg in
Google Scholar
PubMed Close
,
Roberto Negro Division of Endocrinology, V. Fazzi Hospital, Lecce

Search for other papers by Roberto Negro in
Google Scholar
PubMed Close
,
Francesco Vermiglio Cattedra di Endocrinologia, Policlinico Universitario, Messina, Italy

Search for other papers by Francesco Vermiglio in
Google Scholar
PubMed Close
, and
Bijay Vaidya Department of Endocrinology, Royal Devon & Exeter Hospital, Exeter, UK

Search for other papers by Bijay Vaidya in
Google Scholar
PubMed Close

(PTU) is associated with rare but severe liver failure [ 7 , 8 ]. The Endocrine Society guidelines on the management of thyroid disorders, including hyperthyroidism, during pregnancy were published in 2007 [ 9 ]. The aim of this questionnaire survey was

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000336101
Volume/Issue:
Volume 1: Issue 1
Free access
Luigino Dal Maso Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy

Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed Close
,
Daniela Pierannunzio National Centre for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy

Search for other papers by Daniela Pierannunzio in
Google Scholar
PubMed Close
,
Silvia Francisci National Centre for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy

Search for other papers by Silvia Francisci in
Google Scholar
PubMed Close
,
Angela De Paoli Epidemiological Department, Azienda Zero, Padova, Italy

Search for other papers by Angela De Paoli in
Google Scholar
PubMed Close
,
Federica Toffolutti Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy

Search for other papers by Federica Toffolutti in
Google Scholar
PubMed Close
,
Salvatore Vaccarella Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France

Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed Close
,
Silvia Franceschi Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy

Search for other papers by Silvia Franceschi in
Google Scholar
PubMed Close
,
Rossella Elisei Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed Close
,
Ugo Fedeli Epidemiological Department, Azienda Zero, Padova, Italy

Search for other papers by Ugo Fedeli in
Google Scholar
PubMed Close
, and
of the DEPTH Working Group
Search for other papers by of the DEPTH Working Group in
Google Scholar
PubMed Close
of the DEPTH Working Group

Nuclear Medicine Department to perform this treatment. Beginning with the 2006 American Thyroid Association (ATA) guidelines, which were updated in 2009 and 2015, more selective use of RAI has been recommended ( 5 , 6 , 7 ). In 2009, RAI ablation was

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-23-0051
Volume/Issue:
Volume 12: Issue 4
Open access